Dr. Leong research focus on investigating the mechanism of action of potent compounds toward developing new anticancer and antidiabetes drugs. His research adopts an in vitro approach using cell-based and enzymatic assays to identify the various cellular pathways modulated by a potent compound. The research outcome is to understand the mechanism of action of the compound, a prerequisite requirement in developing a new drug entity. In addition, he employs metabolomics to evaluate biomarkers in explaining the treatment outcomes or disease progression. International collaboration has geared his research towards cancer stem cells and utilizing zebrafish as an animal model for cancer. It is believed that cancer stem cells is a subset of cells in tumour that drives chemoresistance and relapse in cancer patients. Therefore, strategies to develop new chemotherapy against the subset of cells is of great interest to tackle the problem.

Dr. Faissal completed his medical degree from University of Wales College of Medicine, Cardiff, United Kingdom in the year 2001. Following which he completed his housemanship and worked as a senior house officer (SHO) in Wales, United Kingdom. He returned to Malaysia in 2005 as a trainee lecturer under the Universiti Teknologi MARA (UiTM) at Selayang Campus. He joined the Masters in Orthopaedic Surgery at University of Malaya (UM) in 2006. During his training, he was appointed as the Chief Resident and completed his clinical masters successfully in the year 2010. He practised orthopaedic surgery at Selayang Hospital and UiTM Sungai Buloh Campus. He was involved in the management of general orthopaedic, advanced trauma cases, arthroplasty and arthroscopy surgery. He then joined the Orthopaedic Oncology Fellowship programme at University Malaya Medical Centre for two years (2013-2015). He passed the National Board of Orthopaedic Oncology examination under the Malaysian Ministry of Health in 2018. After completion of his fellowship, he was appointed as the Head of Orthopaedic Surgery at the Faculty of Medicine, UiTM, Sungai Buloh Campus.   Dr Faissal joined the Faculty of Medicine, University of Malaya as a senior lecturer and consultant orthopaedic surgeon in 2015. He is currently practicing in University Malaya Medical Centre (UMMC) and UM Specialist Centre (UMSC). He is well experienced in general orthopaedic conditions, trauma (fractures), arthroplasty surgery and orthopaedic oncology surgery. He is active in teaching, research and has authored scientific articles in peer-reviewed journals, presented free paper and posters at national and international conferences, such as Malaysian Orthopaedic Association (MOA) Annual Scientific Meeting, International Society of Limb Salvage (ISOLS) and Asia Pacific Musculoskeletal Tumour Society (APMSTS).  He is experience in managing these clinical conditions:  General orthopaedic conditionsDegenerative joints (shoulder, elbow, wrist, hip and knee osteoarthritis)Traumatic fractures (Upper limb, lower limb and pelvis)Lumps / swelling from bone or soft tissue (upper limb, trunk, pelvis and lower limb)Bone and soft tissue tumours from benign to malignant conditions in both adult and children (primary, recurrent and metastatic)Metastatic bone diseasePathological fractures.  He is experience in performing these orthopaedic procedures:Internal and external fixation of upper limb and lower limb fractures. Joint replacement surgery (shoulder, elbow, hip and knee joints) including revision surgery.  Tumour biopsy for bone and soft tissue tumours.  Excision and/or curettage of benign bone and soft tissue tumours.  Wide resection of bone and soft tissue tumours.  Limb salvage surgeries with skeletal reconstruction:  Endoprosthesis reconstructions of upper limb, lower limb and pelvis.  Allograft or autologous bone reconstruction.  Joint arthrodesis / Fusion  Local soft tissue transfer/ flaps / skin grafting  Revision of failed limb reconstructions/ endoprosthesis including prosthetic joint infection  Fixation / Prophylactic fixation of pathological fractures & bone metastasis  Amputation of all levels in upper and lower limbs.

Seon-Hahn KIM, MD, PhD, FACS  Dr. Kim Seon Hahn is Professor and Consultant colorectal surgeon working at Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia, as his new academic position appointed in Sep 2022. He had been Professor of Colorectal Division, Department of Surgery at Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea (2006-2022). He has been specifically interested in robotic and minimally invasive surgery and surgical anatomy in the colorectum during the past 30 years.   Prof. Kim has performed more than 3500 laparoscopic colon and rectal resections and over 1000 robotic rectal resections, mainly for cancer. He performed many live robotic and laparoscopic surgeries at various international congresses and at oversea hospitals. He was honored to give several orations such as; the ‘BJS Lecture’ at the 2015 Congress of European Society of Coloproctology in Dublin, the very first ‘Yasunobu Tsujinaka Memorial Oration’ at the 27th Annual Jagelman/37th Turnbull International Colorectal Symposium 2016 held in Florida, ‘The William Hugh Isbister Lecture’ at the 2019 Saudi-International Colorectal Diseases Forum in Riyadh, Saudi Arabia, and ‘Dr. Pradeep Chowbay Oration’ at Indian Association of Gastrointestinal Endosurgeons (IAGES) 2023 Midterm Conference in Bhopal, India.   Prof. Kim was the Founding President of Korean Association of Robotic Surgeons (KAROS, 2013-15) and the Chairman of the Korean Society of Endoscopic and Laparoscopic Surgeons (KSELS, 2014-16). He was awarded the Yeoh Ghim Seng Professor of Surgery by National University of Singapore (2008-14), and Dr. Anthony PC Yim Professorship in Minimally Invasive Surgery and Innovative Technology by Chinese University of Hong Kong (2011). He has been also invited as visiting professor/scholarship worldwide, including Cleveland Clinic Cleveland, OH, USA (2009), Royal Brisbane Hospital in Australia (2011), National Cheng Gong University in Taiwan (2012/2015), Kumamoto University in Japan (2013), Karolinska Institute Hospital in Stockholm, Sweden (2015/2017), and University of Western Sydney, Australia (2018-2024).